Oncotarget
Latest Episodes
Oncotarget Sponsors 19th International p53 Workshop in Italy
BUFFALO, NY- April 29, 2024 – Oncotarget is a con…
Novel Therapeutic Bispecific Antibodies for B-cell Lymphoma
BUFFALO, NY- April 16, 2024 A new #researchpape
Synergistic Effects of Drug Combinations Targeting AML Cells
Acute myeloid leukemia (AML) is a cancer characte
Exploring the Role of MIA-602 in Overcoming Doxorubicin-resistance in Acute Myeloid Leukemia
BUFFALO, NY- April 10, 2024 A new #researchpape
Identifying Biomarkers for Predicting Paclitaxel Response
Cancer therapy has come a long way from its one-s
Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer
BUFFALO, NY- March 27, 2024 A new #research pap
ABT199/Venetoclax Synergism With Thiotepa in Acute Myeloid Leukemia (AML) Cells
BUFFALO, NY- March 25, 2024 A new #research pap
Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®
BUFFALO, NY- March 20, 2024 A new #research pap
“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny
BUFFALO, NY- March 19, 2024 A new #research per
A New Antibody Capture Method Reveals G-quadruplex Landscape and its Regulation
BUFFALO, NY- March 18, 2024 A new #researchpape